Viewing Study NCT02079532


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-02-24 @ 5:07 AM
Study NCT ID: NCT02079532
Status: COMPLETED
Last Update Posted: 2016-07-29
First Post: 2014-03-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ML19070
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators